Delivery Order SPE2DR25D9311-SPE2DR26FSBF0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,641.28 to DMS Pharmaceutical Group Inc. for the supply of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used for emergency reversal of anticoagulant therapy. The award was issued on July 28, 2025, with an ultimate completion date of August 18, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $72,075.36 for 1,000 unit vials of Kcentra with an ultimate completion date of January 8, 2026. This award carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The delivery order was issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,901.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 units of Kcentra. The award, issued on October 29, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a $3,106.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,592.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The award was issued on November 24, 2025, with an ultimate completion date of December 16, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $3,213.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 1,000 units of Kcentra. The contract is firm fixed-price with no set-aside designation and is scheduled for ultimate completion on November 24, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $17,008.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. The delivery order, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, operates under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc. is performing at its Park...
- The Defense Logistics Agency issued a delivery order valued at $6,797.44 to DMS Pharmaceutical Group Inc. for 500-unit vials of Kcentra on December 23, 2025, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order was awarded without a set-aside designation to the woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. was selected as the awardee based on its established capabilities as a...
- The Defense Logistics Agency awarded a $27,457.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. The delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under...
- The Defense Logistics Agency awarded a delivery order valued at $9,857.28 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on September 27, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents no set-aside designation and will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters. Kcentra is a vitamin K-dependent clotting factor complex used to reverse anticoagulation in emergency...
- SPE2DR25D9311Indefinite Delivery Contract
- SPE2DR25D9311-SPE2DR26FSBF0Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,487.36 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra, a prothrombin complex concentrate used for emergency reversal of warfarin anticoagulation. The award, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the awardee based on its competitive capabilities and established performance as a federal supplier. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply to Department of Defense medical facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support recurring military healthcare needs. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders positions it as a critical supplier within the federal pharmaceutical supply chain for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 1/5/26 |